Inicio › Cáncer del colon y del recto › Minnesota › Rochester
Ensayos clínicos de Cáncer del colon y del recto en Rochester, MN
29 estudios para Cáncer del colon y del recto buscan participantes en centros de Rochester y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ReclutandoFase 1
- Exelixis Clinical Site #68, Rochester
PRE-ISPY Phase I/II Oncology Platform Program
ReclutandoFase 1/2
- Mayo Clinic Comprehensive Cancer Center, Rochester
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- y 3 más
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ReclutandoEstudio observacional
- Mayo Clinic Rochester, Rochester
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
ReclutandoFase 3
- Mayo Clinic in Rochester, Rochester
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
ReclutandoFase 1
- Mayo Clinic - Rochester, Rochester
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
ReclutandoFase 1/2
- Mayo Clinic, Rochester
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
ReclutandoFase 2
- Mayo Clinic in Rochester, Rochester
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
ReclutandoFase 1
- Mayo Clinic Rochester, Rochester
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
ReclutandoFase 2
- Research Site, Rochester
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
ReclutandoEstudio observacional
- Mayo Clinic, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Mayo Clinic, Rochester
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Mayo Clinic (Minnesota), Rochester
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
ReclutandoFase 1
- Mayo Clinic Rochester, Rochester
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
ReclutandoFase 3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
ReclutandoFase 1
- Mayo Clinic Cancer Center, Rochester
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
ReclutandoFase 2
- May Clinic Rochester, Rochester
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ReclutandoFase 2
- Mayo Clinic-Rochester /ID# 273508, Rochester
Lead-212 PSV359 Therapy for Patients With Solid Tumors
ReclutandoFase 1/2
- Mayo Clinic in Rochester, Minnesota, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Mayo Clinic Rochester, Rochester
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
ReclutandoFase 1
- Mayo Clinic Comprehensive Cancer Center, Rochester
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
ReclutandoFase 1
- Mayo Clinic, Rochester, Rochester
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- Mayo Clinic, Rochester
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Mayo Clinic, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
ReclutandoEstudio observacional
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Mayo Clinic, Rochester
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
ReclutandoFase 1/2
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
ReclutandoFase 1/2
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
ReclutandoFase 1/2
- Mayo Clinic in Minnesota, Rochester
Más información sobre Cáncer del colon y del recto en MedlinePlus
Ensayos de Cáncer del colon y del recto en otras ciudades
- Houston, TX102 estudios
- New York City, NY78 estudios
- Nashville, TN69 estudios
- Boston, MA63 estudios
- Los Angeles, CA59 estudios
- Arlington, VA52 estudios
- St. Louis, MO50 estudios
- San Antonio, TX46 estudios
- Philadelphia, PA44 estudios
- Grand Rapids, MI40 estudios
- Baldwin Park, CA37 estudios
- Chicago, IL34 estudios
Otros estudios en Rochester
- Cáncer de seno42 estudios
- Cáncer de pulmón de células no pequeñas37 estudios
- Cáncer metastásico31 estudios
- Cáncer (todos los tipos)30 estudios
- Cáncer de ovario29 estudios
- Mieloma múltiple24 estudios
- Fallo cardíaco22 estudios
- Cáncer de próstata22 estudios
- Cáncer de páncreas22 estudios
- Cáncer de endometrio20 estudios
- Cáncer de pulmón20 estudios
- Leucemia linfocítica crónica18 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.